Medicare Enrolled

Lindsey Cunningham, MSN, APRN, FNP-C

Neurology · Southlake, TX
175 STONEBRIDGE LN STE 100, Southlake, TX 76092
8174212905
Registered in NPPES since 2016
NPI: 1538513973 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Cunningham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Cunningham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Cunningham

Lindsey Cunningham is a neurology specialist in Southlake, TX, with 10 years of NPI registration.

Between the years covered by Open Payments, Cunningham received a total of $11,470 from 73 pharmaceutical and/or device companies across 762 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Cunningham is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years of NPI registration $11,470 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$11,470
Total received (2018-2024)
Avg $2,294/year across 5 years
Top 25% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
762
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,971
2023
$2,634
2022
$4,356
2021
$1,392
2018
$117

Payments by company (2024)

ABBVIE INC.
$358
EMD Serono, Inc.
$333
Genentech USA, Inc.
$251
Lilly USA, LLC
$193
PFIZER INC.
$181
SK Life Science, Inc.
$177
Lundbeck LLC
$176
HARMONY BIOSCIENCES LLC
$155
UCB, Inc.
$140
Abbott Laboratories
$102
LivaNova USA, Inc.
$70
Merz Pharmaceuticals, LLC
$59
JAZZ PHARMACEUTICALS INC.
$56
Grifols USA, LLC
$56
Amneal Pharmaceuticals LLC
$54
Sumitomo Pharma America, Inc.
$49
Teva Pharmaceuticals USA, Inc.
$49
Harmony Biosciences Llc
$47
Azurity Pharmaceuticals, Inc.
$41
Axsome Therapeutics, Inc.
$40
ARGENX US, INC.
$39
Inspire Medical Systems, Inc.
$37
ANI Pharmaceuticals, Inc.
$37
CATALYST PHARMACEUTICALS, INC.
$33
Alexion Pharmaceuticals, Inc.
$31
IDORSIA PHARMACEUTICALS US INC
$28
Otsuka America Pharmaceutical, Inc.
$27
Mallinckrodt Hospital Products Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
Avadel CNS Pharmaceuticals, LLC
$21
SCILEX PHARMACEUTICALS INC.
$21
Eisai Inc.
$19
Aucta Pharmaceuticals, Inc.
$18
Top 3 companies account for 31.7% of 2024 payments
All-time payments by company (2018-2024) ›
Inspire Medical Systems, Inc.
$1,708
ABBVIE INC.
$1,204
Genentech USA, Inc.
$858
SK Life Science, Inc.
$500
UCB, Inc.
$426
EMD Serono, Inc.
$426
Harmony Biosciences LLC
$408
PFIZER INC.
$399
Lilly USA, LLC
$364
Biohaven Pharmaceutical Holding Company Ltd.
$326
Teva Pharmaceuticals USA, Inc.
$309
Biogen, Inc.
$304
IMPEL PHARMACEUTICALS INC.
$288
Biohaven Pharmaceuticals, Inc.
$234
Alexion Pharmaceuticals, Inc.
$208
HARMONY BIOSCIENCES LLC
$203
Sumitomo Pharma America, Inc.
$197
Axsome Therapeutics, Inc.
$190
Lundbeck LLC
$189
ARGENX US, INC.
$170
Grifols USA, LLC
$145
AbbVie Inc.
$145
Amneal Pharmaceuticals LLC
$142
Merz Pharmaceuticals, LLC
$133
Jazz Pharmaceuticals Inc.
$130
Abbott Laboratories
$123
JAZZ PHARMACEUTICALS INC.
$110
Sunovion Pharmaceuticals Inc.
$107
UPSHER-SMITH LABORATORIES LLC
$99
Amgen Inc.
$96
Neurelis, Inc.
$85
Azurity Pharmaceuticals, Inc.
$78
Allergan, Inc.
$75
LivaNova USA, Inc.
$70
MITSUBISHI TANABE PHARMA AMERICA, INC.
$64
GENZYME CORPORATION
$54
Kyowa Kirin, Inc.
$49
Harmony Biosciences Llc
$47
Avion Pharmaceuticals
$47
IDORSIA PHARMACEUTICALS US INC
$45
ANI Pharmaceuticals, Inc.
$37
EISAI INC.
$36
CATALYST PHARMACEUTICALS, INC.
$33
Arbor Pharmaceuticals, Inc.
$31
AstraZeneca Pharmaceuticals LP
$29
ACADIA Pharmaceuticals Inc
$28
Otsuka America Pharmaceutical, Inc.
$27
Horizon Therapeutics plc
$27
Mallinckrodt Hospital Products Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
MDD US Operations, LLC
$24
Mitsubishi Tanabe Pharma America, Inc.
$22
GE HEALTHCARE
$21
Avadel CNS Pharmaceuticals, LLC
$21
Novartis Pharmaceuticals Corporation
$21
BANNER LIFE SCIENCES, LLC
$21
SCILEX PHARMACEUTICALS INC.
$21
Acorda Therapeutics, Inc
$21
CSL Behring
$21
Supernus Pharmaceuticals, Inc.
$20
Eisai Inc.
$19
Almatica Pharma LLC
$18
ZOLL Respicardia, Inc.
$18
Aucta Pharmaceuticals, Inc.
$18
Novo Nordisk Inc
$17
Ipsen Biopharmaceuticals, Inc
$16
Averitas Pharma Inc.
$16
TG THERAPEUTICS, INC.
$15
Catalyst Pharmaceuticals, Inc.
$14
GRT US Holding, Inc.
$14
Merck Sharp & Dohme LLC
$14
Adamas Pharmaceuticals, Inc.
$12
Collegium Pharmaceutical, Inc.
$12
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BRILINTA · BRIUMVI · Briviact · CREXONT · DAXXIFY · DYSPORT · Dhivy · ELYXYB - celecoxib · EMGALITY · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INSPIRE · Inspire Upper Airway Stimulation System · KESIMPTA · KISUNLA · LUMRYZ · Leqembi · MAVENCLAD · Mavenclad · Motpoly XR · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ozempic · PANZYGA · PURIFIED CORTROPHIN GEL · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SUNOSI · Soliris · Sunosi · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZTLido · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Southlake?
Compare neurologists in the Southlake area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
244
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Cunningham is a neurology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Cunningham receive payments from pharmaceutical companies?
Yes. Cunningham received a total of $11,470 from 73 companies across 762 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Cunningham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →